Impax Labs Guides 2014 Capex $40M-45M

Impax Laboratories (NASDAQ: IPXL ) today provided its full year 2014 financial outlook. The Company will discuss its 2014 outlook at the 32(nd) Annual J.P. Morgan Healthcare Conference at 8:00 a.m. Pacific Standard Time today. Individuals may listen to the live or an archived presentation made at the conference, which will be posted